The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H.-W.
Right arrow Articles by Kwon, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H.-W.
Right arrow Articles by Kwon, B. S.
The Journal of Immunology, 2002, 169: 4882-4888.
Copyright © 2002 by The American Association of Immunologists

4-1BB Promotes the Survival of CD8+ T Lymphocytes by Increasing Expression of Bcl-xL and Bfl-11

Hyeon-Woo Lee*, Su-Jung Park*, Beom K. Choi*, Hyun Hwa Kim*, Kyung-Ok Nam* and Byoung S. Kwon2,*,{dagger}

* Immunomodulation Research Center, University of Ulsan, Ulsan, Korea; and {dagger} Louisiana State University Eye Center, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA 70112

4-1BB, a T cell costimulatory receptor, prolongs CD8+ T cell survival. In these studies, 4-1BB stimulation was shown to increase expression of the antiapoptotic genes bcl-xL and bfl-1 via 4-1BB-mediated NF-{kappa}B activation. This signaling pathway was specifically inhibited by PDTC and was different from the pathways that enhanced CD8+ T cell proliferation. The results suggest a role for the antiapoptotic activities of Bcl-xL and Bfl-1 proteins in 4-1BB-mediated CD8+ T cell survival in vivo.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
E. Y. Kim, S.-J. Teh, J. Yang, M. T. Chow, and H.-S. Teh
TNFR2-Deficient Memory CD8 T Cells Provide Superior Protection against Tumor Cell Growth
J. Immunol., November 15, 2009; 183(10): 6051 - 6057.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zhao, Q. J. Wang, S. Yang, J. N. Kochenderfer, Z. Zheng, X. Zhong, M. Sadelain, Z. Eshhar, S. A. Rosenberg, and R. A. Morgan
A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
J. Immunol., November 1, 2009; 183(9): 5563 - 5574.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
Y. H. Kim, B. K. Choi, W. J. Kang, K. H. Kim, S. W. Kang, A. L. Mellor, D. H. Munn, and B. S. Kwon
IFN-{gamma}-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo
J. Leukoc. Biol., May 1, 2009; 85(5): 817 - 825.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. H. Kim, B. K. Choi, H. S. Oh, W. J. Kang, R. S. Mittler, and B. S. Kwon
Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
Mol. Cancer Ther., February 1, 2009; 8(2): 469 - 478.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. H. Y. Lin, B. J. Sedgmen, T. J. Moraes, L. M. Snell, D. J. Topham, and T. H. Watts
Endogenous 4-1BB Ligand Plays a Critical Role in Protection from Influenza-Induced Disease
J. Immunol., January 15, 2009; 182(2): 934 - 947.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
O. Murillo, A. Arina, S. Hervas-Stubbs, A. Gupta, B. McCluskey, J. Dubrot, A. Palazon, A. Azpilikueta, M. C. Ochoa, C. Alfaro, et al.
Therapeutic Antitumor Efficacy of Anti-CD137 Agonistic Monoclonal Antibody in Mouse Models of Myeloma
Clin. Cancer Res., November 1, 2008; 14(21): 6895 - 6906.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. H. Kim, B. K. Choi, K. H. Kim, S. W. Kang, and B. S. Kwon
Combination Therapy with Cisplatin and Anti-4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity
Cancer Res., September 15, 2008; 68(18): 7264 - 7269.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. G. Mack, A. K. Lanham, B. E. Palmer, L. A. Maier, T. H. Watts, and A. P. Fontenot
4-1BB Enhances Proliferation of Beryllium-Specific T Cells in the Lung of Subjects with Chronic Beryllium Disease
J. Immunol., September 15, 2008; 181(6): 4381 - 4388.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Sabbagh, G. Pulle, Y. Liu, E. N. Tsitsikov, and T. H. Watts
ERK-Dependent Bim Modulation Downstream of the 4-1BB-TRAF1 Signaling Axis Is a Critical Mediator of CD8 T Cell Survival In Vivo
J. Immunol., June 15, 2008; 180(12): 8093 - 8101.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Wang, T. Wen, J.-P. Routy, N. F. Bernard, R. P. Sekaly, and T. H. Watts
4-1BBL Induces TNF Receptor-Associated Factor 1-Dependent Bim Modulation in Human T Cells and Is a Critical Component in the Costimulation-Dependent Rescue of Functionally Impaired HIV-Specific CD8 T Cells
J. Immunol., December 15, 2007; 179(12): 8252 - 8263.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Habib-Agahi, T. T. Phan, and P. F. Searle
Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells
Int. Immunol., December 1, 2007; 19(12): 1383 - 1394.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. H. Yi, H. Nechushtan, W. J. Bowers, G. R. Walker, Y. Zhang, D. G. Pham, E. R. Podack, H. J. Federoff, K. A. Tolba, and J. D. Rosenblatt
Adoptively Transferred Tumor-Specific T Cells Stimulated Ex vivo Using Herpes Simplex Virus Amplicons Encoding 4-1BBL Persist in the Host and Show Antitumor Activity In vivo
Cancer Res., October 15, 2007; 67(20): 10027 - 10037.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S.-J. Lee, R. J. Rossi, S.-K. Lee, M. Croft, B. S. Kwon, R. S. Mittler, and A. T. Vella
CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent
J. Immunol., August 15, 2007; 179(4): 2203 - 2214.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Wolfl, J. Kuball, W. Y. Ho, H. Nguyen, T. J. Manley, M. Bleakley, and P. D. Greenberg
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
Blood, July 1, 2007; 110(1): 201 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Zhang, R. E. Sadun, R. S. Arias, M. L. Flanagan, S. M. Sachsman, Y.-C. Nien, L. A. Khawli, P. Hu, and A. L. Epstein
Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors
Clin. Cancer Res., May 1, 2007; 13(9): 2758 - 2767.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Niu, S. Strahotin, B. Hewes, B. Zhang, Y. Zhang, D. Archer, T. Spencer, D. Dillehay, B. Kwon, L. Chen, et al.
Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice
J. Immunol., April 1, 2007; 178(7): 4194 - 4213.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. D. Saibil, R. G. Jones, E. K. Deenick, N. Liadis, A. R. Elford, M. G. Vainberg, H. Baerg, J. R. Woodgett, S. Gerondakis, and P. S. Ohashi
CD4+ and CD8+ T Cell Survival Is Regulated Differentially by Protein Kinase C{theta}, c-Rel, and Protein Kinase B
J. Immunol., March 1, 2007; 178(5): 2932 - 2939.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Houtenbos, T. M. Westers, A. Dijkhuis, T. D. de Gruijl, G. J. Ossenkoppele, and A. A. van de Loosdrecht
Leukemia-Specific T-Cell Reactivity Induced by Leukemic Dendritic Cells Is Augmented by 4-1BB Targeting
Clin. Cancer Res., January 1, 2007; 13(1): 307 - 315.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S.-W. Lee, Y. Park, A. Song, H. Cheroutre, B. S. Kwon, and M. Croft
Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses
J. Immunol., October 1, 2006; 177(7): 4464 - 4472.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Minamimura, W. Gao, and T. Maki
CD4+ Regulatory T Cells Are Spared from Deletion by Antilymphocyte Serum, a Polyclonal Anti-T Cell Antibody
J. Immunol., April 1, 2006; 176(7): 4125 - 4132.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Pulle, M. Vidric, and T. H. Watts
IL-15-Dependent Induction of 4-1BB Promotes Antigen-Independent CD8 Memory T Cell Survival.
J. Immunol., March 1, 2006; 176(5): 2739 - 2748.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Rabu, A. Quemener, Y. Jacques, K. Echasserieau, P. Vusio, and F. Lang
Production of Recombinant Human Trimeric CD137L (4-1BBL): CROSS-LINKING IS ESSENTIAL TO ITS T CELL CO-STIMULATION ACTIVITY
J. Biol. Chem., December 16, 2005; 280(50): 41472 - 41481.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Rasooly, G. U. Schuster, J. P. Gregg, J.-H. Xiao, R. A. S. Chandraratna, and C. B. Stephensen
Retinoid X Receptor Agonists Increase Bcl2a1 Expression and Decrease Apoptosis of Naive T Lymphocytes
J. Immunol., December 15, 2005; 175(12): 7916 - 7929.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Bukczynski, T. Wen, C. Wang, N. Christie, J.-P. Routy, M.-R. Boulassel, C. M. Kovacs, K. S. MacDonald, M. Ostrowski, R.-P. Sekaly, et al.
Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L
J. Immunol., November 15, 2005; 175(10): 6378 - 6389.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S.-C. Lee, S.-A. Ju, H.-N. Pack, S.-K. Heo, J.-H. Suh, S.-M. Park, B.-K. Choi, B. S. Kwon, and B. S. Kim
4-1BB (CD137) Is Required for Rapid Clearance of Listeria monocytogenes Infection
Infect. Immun., August 1, 2005; 73(8): 5144 - 5151.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Hendriks, Y. Xiao, J. W. A. Rossen, K. F. van der Sluijs, K. Sugamura, N. Ishii, and J. Borst
During Viral Infection of the Respiratory Tract, CD27, 4-1BB, and OX40 Collectively Determine Formation of CD8+ Memory T Cells and Their Capacity for Secondary Expansion
J. Immunol., August 1, 2005; 175(3): 1665 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Zhang and Y.-W. He
The Antiapoptotic Protein Bcl-xL Is Dispensable for the Development of Effector and Memory T Lymphocytes
J. Immunol., June 1, 2005; 174(11): 6967 - 6973.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Arens, P. A. Baars, M. Jak, K. Tesselaar, M. van der Valk, M. H. J. van Oers, and R. A. W. van Lier
Cutting Edge: CD95 Maintains Effector T Cell Homeostasis in Chronic Immune Activation
J. Immunol., May 15, 2005; 174(10): 5915 - 5920.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K.-O. Nam, H. Kang, S.-M. Shin, K.-H. Cho, B. Kwon, B. S. Kwon, S.-J. Kim, and H.-W. Lee
Cross-Linking of 4-1BB Activates TCR-Signaling Pathways in CD8+ T Lymphocytes
J. Immunol., February 15, 2005; 174(4): 1898 - 1905.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
M. Lun, P. L. Zhang, P. K. Pellitteri, A. Law, T. L. Kennedy, and R. E. Brown
Nuclear Factor-kappaB Pathway as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma: Pharmaceutical and Molecular Validation in Human Cell Lines Using Velcade and siRNA/NF-{kappa}B.
Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 251 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Ito, Q. Li, A. B. Shreiner, R. Okuyama, M. N. Jure-Kunkel, S. Teitz-Tennenbaum, and A. E. Chang
Anti-CD137 Monoclonal Antibody Administration Augments the Antitumor Efficacy of Dendritic Cell-Based Vaccines
Cancer Res., November 15, 2004; 64(22): 8411 - 8419.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Dawicki, E. M. Bertram, A. H. Sharpe, and T. H. Watts
4-1BB and OX40 Act Independently to Facilitate Robust CD8 and CD4 Recall Responses
J. Immunol., November 15, 2004; 173(10): 5944 - 5951.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
R. Arens, K. Schepers, M. A. Nolte, M. F. van Oosterwijk, R. A.W. van Lier, T. N.M. Schumacher, and M. H.J. van Oers
Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8+ T Cell Formation
J. Exp. Med., June 7, 2004; 199(11): 1595 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. E. Gamadia, E. M. M. van Leeuwen, E. B. M. Remmerswaal, S.-L. Yong, S. Surachno, P. M. E. Wertheim-van Dillen, I. J. M. ten Berge, and R. A. W. van Lier
The Size and Phenotype of Virus-Specific T Cell Populations Is Determined by Repetitive Antigenic Stimulation and Environmental Cytokines
J. Immunol., May 15, 2004; 172(10): 6107 - 6114.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B. K. Choi, J. S. Bae, E. M. Choi, W. J. Kang, S. Sakaguchi, D. S. Vinay, and B. S. Kwon
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells
J. Leukoc. Biol., May 1, 2004; 75(5): 785 - 791.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Petrovas, Y. M. Mueller, I. D. Dimitriou, P. M. Bojczuk, K. C. Mounzer, J. Witek, J. D. Altman, and P. D. Katsikis
HIV-Specific CD8+ T Cells Exhibit Markedly Reduced Levels of Bcl-2 and Bcl-xL
J. Immunol., April 1, 2004; 172(7): 4444 - 4453.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. M. Bertram, W. Dawicki, B. Sedgmen, J. L. Bramson, D. H. Lynch, and T. H. Watts
A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo
J. Immunol., January 15, 2004; 172(2): 981 - 988.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Nencioni, K. Lauber, F. Grunebach, L. Van Parijs, C. Denzlinger, S. Wesselborg, and P. Brossart
Cyclopentenone Prostaglandins Induce Lymphocyte Apoptosis by Activating the Mitochondrial Apoptosis Pathway Independent of External Death Receptor Signaling
J. Immunol., November 15, 2003; 171(10): 5148 - 5156.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.